Article
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.
Clinical and translational science - 1 Nov 2022
Campodónico Diana María, Zubiaur Pablo, Soria-Chacartegui Paula, Casajús Ana, Villapalos-García Gonzalo, Navares-Gómez Marcos, Gómez-Fernández Antía, Parra-Garcés Raúl, Mejía-Abril Gina, Román Manuel, Martín-Vílchez Samuel, Ochoa Dolores, Abad-Santos Francisco
Abstract excerpt
Cinitapride is a gastrointestinal prokinetic drug, prescribed for the treatment of functional dyspepsia, and as an adjuvant therapy for gastroesophageal reflux disease. In this study, we aimed to explore the impact of relevant variants in CYP3A4 and CYP2C8 and other pharmacogenes, along with demographic characteristics, on cinitapride pharmacokinetics and safety; and to evaluate the impact of CYP2C8 alleles on...
Topics
Join the communities discussing this publication.
